瑞珍斯生物

最新新闻

• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on RegenXBio (RGNX)
  TipRanks · 2026/6/22
• 评级变动
  Leerink Partners Maintains Regenxbio(RGNX.US) With Buy Rating, Announces Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• 评级变动
  Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $6.25
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• 评级变动
  A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $42
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• 评级变动
  H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $26
  \u5e02\u573a\u8d44\u8baf · 2026/6/6
• 评级变动
  A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Baird Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $32
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $15 to $32
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  Clear Street Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $42
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 评级变动
  Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• 评级变动
  H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• Mizuho Securities Initiates Regenxbio(RGNX.US) With Buy Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Sagimet Biosciences, Inc. Class A (SGMT)
  TipRanks · 2026/8/25
• 评级变动
  BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/8/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。